Treatment of Rheumatoid Arthiritis with Unani formulations
Phase 2
- Conditions
- Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvementHealth Condition 2: null- Waja ul Mafasil (Rheumatoid Arthritis)
- Registration Number
- CTRI/2013/12/004199
- Lead Sponsor
- Monetary Support Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
•Patients of either sex in the age group of 20-60
•Patients fulfilling the ACR criteria for rheumatoid arthritis i.e the 2010 American College of Rheumatology/European League Against Rheumatism classification Criteria for rheumatoid arthritis
Exclusion Criteria
•Patients having Gout, or complicated rheumatoid arthritis associated with deformity.
•Abnormality in any investigation done at baseline (SGOT, SGPT and ALP,Sr Creatinine, B.Urea would be considered abnormal if raised 2 ½ times the normal value )
•Overweight subjects â?? BMI 35
•Disorders requiring long term treatment
•Drug addicts ( Alcohol, drugs )
•Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in signs and symptomsTimepoint: 12 weeks
- Secondary Outcome Measures
Name Time Method Hematological and biochemical assessments for safetyTimepoint: 12 weeks